biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by chance18on Feb 13, 2019 10:59am

607 Views

Post# 29357994

What’s up?

The BIO CEO & Investor Conference concluded today having drawn nearly 1,300 attendees representing 30 countries, making the event a global attraction. A record number of investors and it looks like no one is interested .
We sit at 50 cents with such great science and no rush from new investors to pick up shares . Something doesn’t add up here . I’ve been here for years and there comes a time when you ask yourself why . Am I smarter than everyone else and they just don’t see the potential
Come on Mr Day let’s see if you really got it or not. Let’s not blame the stock price on a few disgruntled shareholders or the markets . Where’s all those new investors that Stern was going to bring in ?

Bullboard Posts

Get a better understanding of the psychology of options trading